Market Cap (In DKK)
46.71 Million
Revenue (In DKK)
-
Net Income (In DKK)
-26.04 Million
Avg. Volume
31.00
- Currency
- DKK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 407.0-1525.0
- PE
- -
- EPS
- -
- Beta Value
- 0.079
- ISIN
- DK0062502894
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Jakob Færch Bendtsen
- Employee Count
- -
- Website
- https://www.orphazyme.com
- Ipo Date
- 2017-11-21
- Details
- Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
More Stocks
-
GOLDIAMGoldiam International Limited
GOLDIAM
-
LEE
-
9577
-
SSRSF
-
PEXIPPexip Holding ASA
PEXIP
-
JAYAGROGNJayant Agro-Organics Limited
JAYAGROGN
-
600616
-
APN